A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma
- L. Goyal
- D. DiToro
- et al.
- 2025
- Annals of Oncology
Publications
15 results for Gad Getz
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors
- Risa Burr
- Ignaty Leshchiner
- et al.
- 2024
- Nat. Cancer
Latent human herpesvirus 6 is reactivated in CAR T cells
- Caleb A. Lareau
- Yajie Yin
- et al.
- 2023
- Nature
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations
- Andreas Varkaris
- Ferran Fece de la Cruz
- et al.
- 2023
- Cancer Discovery
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples
- Jasneet Kaur Khalsa
- Justin Cha
- et al.
- 2023
- Blood
Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors
- Joseph Toker
- J Bryan Iorgulescu
- et al.
- 2023
- Clinical cancer research : an official journal of the American Association for Cancer Research
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
- Erin M. Parry
- Ignaty Leshchiner
- et al.
- 2023
- Nature Medicine
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
- Nicholas J. Haradhvala
- Mark B. Leick
- et al.
- 2022
- Nature Medicine
Molecular map of chronic lymphocytic leukemia and its impact on outcome
- Binyamin A. Knisbacher
- Ziao Lin
- et al.
- 2022
- Nature Genetics
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
- Ashish Noronha
- Nishanth Belugali Nataraj
- et al.
- 2022
- Cancer Discovery